These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27802840)

  • 1. miR-374 promotes myocardial hypertrophy by negatively regulating vascular endothelial growth factor receptor-1 signaling.
    Lee JS; Song DW; Park JH; Kim JO; Cho C; Kim DH
    BMB Rep; 2017 Apr; 50(4):208-213. PubMed ID: 27802840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-625-5p Inhibits Cardiac Hypertrophy Through Targeting STAT3 and CaMKII.
    Cai K; Chen H
    Hum Gene Ther Clin Dev; 2019 Dec; 30(4):182-191. PubMed ID: 31617427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
    Wang YS; Zhou J; Hong K; Cheng XS; Li YG
    Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
    Liu X; Xu Y; Deng Y; Li H
    Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
    Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
    Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
    Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
    Song G; Zhu L; Ruan Z; Wang R; Shen Y
    Biochem Biophys Res Commun; 2019 Nov; 519(4):682-688. PubMed ID: 31543343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIδ.
    He J; Jiang S; Li FL; Zhao XJ; Chu EF; Sun MN; Chen MZ; Li H
    J Investig Med; 2013 Mar; 61(3):604-12. PubMed ID: 23360843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
    Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
    Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy.
    You XY; Huang JH; Liu B; Liu SJ; Zhong Y; Liu SM
    Biochemistry (Mosc); 2014 Jun; 79(6):538-44. PubMed ID: 25100012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
    Xiang Y; Zhang Y; Tang Y; Li Q
    Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways.
    Kim JO; Song DW; Kwon EJ; Hong SE; Song HK; Min CK; Kim DH
    PLoS One; 2015; 10(3):e0122509. PubMed ID: 25767890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
    Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
    Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
    Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
    Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-101b attenuates cardiomyocyte hypertrophy by inhibiting protein kinase C epsilon signaling.
    Lee JS; Yang DK; Park JH; Kim JO; Park WJ; Cho C; Kim DH
    FEBS Lett; 2017 Jan; 591(1):16-27. PubMed ID: 27925653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-31-5p suppresses myocardial hypertrophy by targeting Nfatc2ip.
    Zhao L; Qian X; Ren Z; Wang A
    J Cell Mol Med; 2024 Jun; 28(12):e18413. PubMed ID: 38894694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MicroRNA-124 Reduces Cardiomyocyte Apoptosis Following Myocardial Infarction via Targeting STAT3.
    He F; Liu H; Guo J; Yang D; Yu Y; Yu J; Yan X; Hu J; Du Z
    Cell Physiol Biochem; 2018; 51(1):186-200. PubMed ID: 30439699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.